JSC “Farmak” will defend its intellectual property rights to the well-known trademark Corvalol Corvalolum at the hearing of the Grand Chamber of the Supreme Court of Ukraine scheduled for June 25, 2019.
JSC “Farmak” stands for a civilized competition and defends its rights to the well-known trademark Corvalol Corvalolum.
The hearing will be held at 04:00 p.m. at 8 Pylypa Orlyka Str., at the room of the Supreme Court.
It should be reminded that having examined the appeal of Pharmaceutical Firm “Darnitsa”, Kyiv Commercial Court of Appeal quashed the decision of the Appeals Chamber of the Ministry of Economic Development and Trade on the recognition of CORVALOL CORVALOLUM as well-known trademark.
The motions filed by both the Ministry of Economic Development and Trade as the defendant, and JSC “Farmak” as the third party were dismissed, evidencing biased proceedings in the appellate instance.
Historically, Farmak has owned the trademark “CORVALOL”, manufactured since 1960. “Corvalol” was developed in 1960 by Lomonosov Kyiv Chemical and Pharmaceutical Plant, the successor of which is JSC “Farmak”.
JSC “Farmak” has been established on the basis of Lomonosov Kyiv Chemical and Pharmaceutical Plant in 1925, specialized in manufacturing of pharmaceutical substances and radiopaque contrast agents in the territory of the former Soviet Union.
A new stage of the company’s development began after the transformation of the chemical plant into a robust pharmaceutical company manufacturing finished dosage forms in 1995.
Preparation for manufacturing of Corvalol was initiated by Lomonosov Kyiv Chemical and Pharmaceutical Plant, the successor of which is JSC “Farmak”.
The medicinal product was developed by Senior Chemist V.Ya. Yakovleva.
The first batch of Corvalol was released under the order of Lomonosov Kyiv Chemical and Pharmaceutical Plant dated October 15, 1960.
Since then, Lomonosov Kyiv Chemical and Pharmaceutical Plant has been the only manufacturer of Corvalol in the territory of the former USSR.
Since 1991, JSC “Farmak” has been the only manufacturer of this medicinal product in the former Soviet Union.
Furthermore, Corvalol trademark is protected in 15 countries of Europe and Central Asia: Germany, Poland, Lithuania, Estonia, Latvia, Belarus, Moldova, Romania, Bulgaria, Turkmenistan, Armenia, Georgia, Azerbaijan, Tajikistan, Kyrgyzstan, and Kazakhstan.
The use of the trademark Corvalol Corvalolum is generally confirmed by packaging for the period from 1991 to 2001 inclusive.
The book Visionary (in Ukrainian: Vizioner («Візіонер»)) about Filya Zhebrovska, the owner of the largest Ukrainian pharmaceutical company Farmak, was published in April by Burda Publishing House. The biography tells about the life of a person who managed to steer the Soviet enterprise out of the crisis and transform it into a modern European manufacturing [...
Hospitals require primary support as they are not yet equipped with the devices necessary for effective treatment of COVID-19. The Zhebrivski Family Charitable Foundation paid for and now is expecting the delivery of three ORICARE V8600 lung ventilators (manufactured in the USA), purchased Acclarix LX8 digital ultrasound diagnostic system and other equipment...
The Zhebrivski Family Charitable Foundation (successor to the Farmak Charitable Foundation) provided each retired employee of Farmak with essential medicines The elderly people having retired from JSC Farmak will receive packages with protective masks and medicines. The packages include antiviral, sedative, anti-allergy medicines, as well as medicines for tr...